TY - JOUR
T1 - Characterizing the DNA binding modes of a topoisomerasei-poisoning terbenzimidazole
T2 - Evidence for both intercalative and minor groove binding properties
AU - Pilch, Daniel S.
AU - Xu, Zhitao
AU - Sun, Qun
AU - Lavoie, Edmond J.
AU - Liu, Leroy F.
AU - Geacintov, Nicholas E.
AU - Breslauer, Kenneth J.
PY - 1996
Y1 - 1996
N2 - We have used a broad range of spectroscopic and viscometric techniques to demonstrate that the complexation of a cytotoxic, topoisomerase I-poisoning terbenzimidazole (5PTB) with the poly(dA)•poly(dT) duplex exhibits properties characteristic of both intercalation and minor groove binding. Our results reveal the following features: (i) Optical melting profiles reveal that 5PTB binding enhances the thermal stability of the poly(dA)• poly(dT) duplex; (ii) Fluorescence-detected 5PTB binding to the poly(dA)•poly(dT) duplex reveals four apparent "site sizes," ranging from 1 to 13 base pairs (bp) per bound drug; (iii) Flow linear dichroism data suggest conformational heterogeneity among the poly(dA)•poly(dT)-bound 5PTB molecules, with substantial contributions from drug molecules bound in the minor groove; (iv) Fluorescence resonance energy transfer data reveal properties characteristic of a significant contribution from an intercalative mode of binding; (v) Viscometric, fluorescence quenching, and netropsin competition data are consistent with 5PTB binding to poly(dA)•poly(dT) by "mixed" modes, which are operationally defined as single or multiple binding populations that individually and/or collectively express both intercalative and minor groove binding properties. We comment on a potential correlation between drugs that exhibit such "mixed" mode binding motifs and those that express antineoplastic activity through inhibition of topoisomerase I.
AB - We have used a broad range of spectroscopic and viscometric techniques to demonstrate that the complexation of a cytotoxic, topoisomerase I-poisoning terbenzimidazole (5PTB) with the poly(dA)•poly(dT) duplex exhibits properties characteristic of both intercalation and minor groove binding. Our results reveal the following features: (i) Optical melting profiles reveal that 5PTB binding enhances the thermal stability of the poly(dA)• poly(dT) duplex; (ii) Fluorescence-detected 5PTB binding to the poly(dA)•poly(dT) duplex reveals four apparent "site sizes," ranging from 1 to 13 base pairs (bp) per bound drug; (iii) Flow linear dichroism data suggest conformational heterogeneity among the poly(dA)•poly(dT)-bound 5PTB molecules, with substantial contributions from drug molecules bound in the minor groove; (iv) Fluorescence resonance energy transfer data reveal properties characteristic of a significant contribution from an intercalative mode of binding; (v) Viscometric, fluorescence quenching, and netropsin competition data are consistent with 5PTB binding to poly(dA)•poly(dT) by "mixed" modes, which are operationally defined as single or multiple binding populations that individually and/or collectively express both intercalative and minor groove binding properties. We comment on a potential correlation between drugs that exhibit such "mixed" mode binding motifs and those that express antineoplastic activity through inhibition of topoisomerase I.
KW - DNA base-drug resonance energy transfer
KW - Flow linear dichroism
KW - Fluorescence quenching
KW - Förster critical distance
KW - Mixed mode DNA binding
UR - http://www.scopus.com/inward/record.url?scp=0030002584&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030002584&partnerID=8YFLogxK
M3 - Article
C2 - 8874049
AN - SCOPUS:0030002584
SN - 1055-9612
VL - 13
SP - 115
EP - 133
JO - Drug Design and Discovery
JF - Drug Design and Discovery
IS - 3-4
ER -